Guidance Documents

The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) has rescinded the exemptions for certain consumer-style grenades (e.g., flashbang grenades, smoke grenades) as they have been determined by ATF to pose a risk to public safety. The purpose of this letter is to provide guidance on the requirements for these explosive devices that ATF previously exempted as special explosive devices (SEDs) pursuant to the regulation at 27 CFR § 555.32.

This document discusses and explains the requirements of the ADA's integration mandate and the Supreme Court's decision in Olmstead v. L.C. ex rel. Zimring, 527 U.S. 581 (1999), as applied to segregated employment settings and facility-based day programs.

The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) authorizes an alternate method or procedure to the explosives recordkeeping requirements contained in Title 27, Code of Federal Regulations (CFR), Part 555, Subpart G. Specifically, ATF authorizes federal explosives licensees and permittees (FEL/Ps) to maintain their records electronically instead of in paper format, provided the conditions set forth in this ruling are met. This ruling supersedes ATF Ruling 2007-1.

This is a revision of a previously approved and posted Q&A (EO-DEA182), that was not considered guidance. This Q&A provides information regarding the training requirement included in CAA of 2023.  All practitioners, who are not solely a veterinarian, must attest to satisfying the training, credentialing, or educational requirements identified in the CAA in order to obtain a new or renewal DEA registration. 

This guidance document provides information regarding a Drug Enforcement Administration (DEA)-registered practitioner’s attestation of the training requirement in the recently enacted Consolidated Appropriations Act of 2023 (CAA).  While specifically targeted to the treatment of or screening for OUD, this training is required for all qualified practitioners applying for or renewing a registration to dispense controlled substances in schedules II-V.

This guidance document provides clarification regarding the regulatory requirement for persons engaging in regulated transactions in listed chemicals to report transactions involving an extraordinary quantity, an uncommon method of payment or delivery, or other circumstances indicating a potential use of listed chemicals in violation of the law.  This guidance is being sent via email to all Drug Enforcement Administration (DEA) listed chemical registrants and regulated persons.

The purpose of this Open Letter is to notify you of an important change to the procedure you may follow to comply with the Brady Handgun Violence Protection Act (Brady Act), codified at 18 U.S.C. § 922(t), when transferring a firearm to an unlicensed person. Specifically, the North Carolina pistol purchase permit may no longer be used as an alternative to the National Instant Criminal Background Check System (NICS) check requirement.

This is a revision of previously approved and posted Q&As, that were published on March 31, 2020.  DEA-DC-9.  This  document replaces three of the questions posted within DEA-DC-9 and provides information regarding what EPCS is, remote identity proofing, and if qualified practitioners are allowed to use EPCS to issue prescriptions for CIII-V CS approved by the FDA for MOUD.

The Bureau of Alcohol, Tobacco, Firearms and Explosives (“ATF”) is issuing this open letter to assist Federal Firearms Licensees (“FFLs”) in understanding their obligations when they choose to provide firearm storage services to their customers and the public.

This Practitioner’s Manual has been prepared by the DEA, Diversion Control Division, as a guide to assist practitioners in their understanding of the federal Controlled Substances Act and its implementing regulations as they pertain to their profession.